Choose a CauseBasic Needs Community Environment Health and Safety
Opportunity |
$75
 There are new technologies through which we are developing an understanding of genes proteins and networks – offering the possibility to shift from a one-size fits all model. more $30
 Your gift of $30 provides one hour of time in the lab for an AFAR researcher conducting ground-breaking research on aging and age-related diseases, including cancer, heart disease, Alzheimer's disease, and osteoporosis. more $50
 Memorial Sloan-Kettering Cancer Center is one of only a few centers that offer computer-assisted family history analysis. more $50
 Your gift will support current research into new agents to treat lung cancer and prevent its recurrence. Memorial Sloan-Kettering researchers are evaluating new drugs for lung cancer, including getifinib (Iressa). more $250
 Your generous gift will buy one share of the ABC² Angel Investor Fund* (multiple shares are available) to fast-track cutting edge brain cancer research advancements. more $100
 Your gift will provide analysis of DNA gel samples. Agarose gel electrophoresis is the easiest and commonest way of separating and analyzing DNA. The purpose of the gel might be to look at the DNA, to quantify it or to isolate a particular band. The DNA is visualised in the gel by addition of ethidium bromide. more $67
 This gift will help BCRF provide $250,000 to one dedicated researcher hoping to find a cure for breast cancer in our lifetime. more $50
 Your gift will support the research of our physicians and scientists who continue to pioneer new medical treatments in breast cancer research such as immunotherapy, including vaccines and antibodies. more $35
 You gift will help foster collaboration across institutional lines and hasten a cure for brain cancer. To accelerate the transition of therapies into clinical studies for patients, ABC² has initiated a strategic collaboration, the ABC² Clinical Network. more $100
 Accelerate Brain Cancer Cure brings together researchers, clinicians, the biotech and pharmaceutical industry and government to fund research that translates promising laboratory successes into clinically meaningful improvements for patients. more |
